Pronóstico del mercado de agentes de embolización en Oriente Medio y África hasta 2028: impacto de COVID-19 y análisis regional por producto (bobinas, tapones, perlas/partículas, globos desmontables, pegamento, esponja, embólicos líquidos, esclerosantes, agentes precipitantes y otros), aplicación ( Oncología, Neurología, Urología, Cardiología, Enfermedades Vasculares Periféricas y otros) y Usuario Final (Hospitales, Centros Cardíacos, Centros de Cirugía Ambulatoria y otros)
Introducción al mercado
Medio Oriente y Asia El mercado africano de agentes de embolización se analiza en función de Arabia Saudita, Emiratos Árabes Unidos, Sudáfrica y el resto de Oriente Medio y Europa. África. En el escenario actual del mercado, la región de Medio Oriente está experimentando una creciente incidencia de enfermedades crónicas como accidentes cerebrovasculares, trastornos neurológicos, cáncer y un aumento de la población geriátrica, adaptando estilos de vida poco saludables. Además, se prevé que la aceptación y la instalación de tecnologías modernas impulsen el crecimiento del mercado en esta región. Los factores clave que impulsan el mercado incluyen la creciente incidencia de enfermedades crónicas y el envejecimiento de la población. El aumento de factores de riesgo como la obesidad, la presión arterial alta, la falta de actividad física, y fumar contribuyen a un aumento de los casos de ECV. Las enfermedades cardiovasculares son la principal causa de muerte y representan más del 45 % de todas las muertes. Arabia Saudita está experimentando cambios significativos en el nivel de vida de la población y estilo de vida; los cambios han llevado a un aumento en el consumo de alimentos grasos y de mala calidad. La consecuencia de un cambio de estilo de vida ha resultado en un aumento de las tasas de enfermedades cardiovasculares. Otro factor importante que aumenta los casos de ECV en Arabia Saudita es el aumento de la población geriátrica. Según el informe sobre el envejecimiento de la población en Arabia Saudita, se prevé que la proporción de personas en Arabia Saudita de 60 años o más será el 25% de la población total de 40 millones para fines de 2050. Además, el número de personas de 80 años o más Se espera que alcance 1,6 millones, o el 4% de la población total en el mismo período. Además, el gobierno está invirtiendo fuertemente en la construcción de hospitales para construir un sector sanitario sólido en Arabia Saudita. Por ejemplo, en 2019, el Ministerio de Salud planeó construir 35 hospitales en todo el país. La mejora del gasto sanitario y el aumento de las iniciativas gubernamentales en Arabia Saudita son factores para el crecimiento del mercado de agentes de embolización. Según el Consejo de Cooperación del Golfo (CCG), Arabia Saudita planea invertir 250.000 millones de rupias (66.670 millones de dólares) en infraestructura sanitaria e impulsar la participación del sector privado del actual 40 por ciento al 65 por ciento para 2030.
El sector de la salud en los EAU ha experimentado una cantidad considerable de cambios en infraestructura y procedimientos para posicionarse como un proveedor de atención médica líder. Estas mejoras han atraído inversiones continuas para la mejora de la infraestructura física y física durante la pandemia de COVID-19. Debido a la COVID-19, un número sustancial de operaciones quirúrgicas electivas planificadas fueron canceladas o pospuestas en esta región. Desde principios de 2020, la pandemia de COVID-19 ha causado enormes impactos socioeconómicos y de salud, que son Es probable que continúe también en 2021. La pandemia ha causado perturbaciones en los servicios de salud y ha impactado la capacidad de los países para abordar y responder a las enfermedades no transmisibles (ENT). Además, las incertidumbres económicas y los conflictos actuales están empeorando las condiciones en Medio Oriente y África. Por ejemplo, países como Siria, Libia y Yemen están sufriendo conflictos violentos y no han podido implementar ninguna medida de salud pública; Además, Irán se encontraba en una profunda recesión económica debido a las sanciones de Estados Unidos.
Descripción general y dinámica del mercado
El mercado de agentes de embolización en Oriente Medio y Asia. Se espera que África crezca de 124,75 millones de dólares en 2021 a 194,31 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 6,5% de 2021 a 2028. Aumento de la incidencia de tumores y aneurismas; Los agentes de embolización se utilizan para detener de forma aguda el flujo en un vaso sanguíneo o territorio vascular mediante oclusión mecánica. La embolización es un procedimiento común en radiología intervencionista. Los agentes embolizantes, como las microesferas embólicas (perlas), se utilizan para restringir el suministro vascular de los tumores y pueden cargarse con medicamentos quimioterapéuticos, que eluyen y difunden en el tejido. Los agentes embólicos líquidos se utilizan para impedir el suministro de sangre a un aneurisma o tumor. Ayuda a prevenir que aneurismas y tumores crezcan y causen daño a órganos esenciales. Por lo tanto, la creciente prevalencia de aneurismas y cánceres está creando una gran demanda en Oriente Medio y Europa. África mercado de agentes de embolización.
Segmentos de mercado clave
Según el producto, el mercado se segmenta en espirales, perlas/partículas, tapones, globos desmontables, pegamento, esponja, embólicos líquidos, esclerosantes, agentes precipitantes, otros. El segmento de perlas/partículas tuvo la mayor participación del mercado en 2020. Según las bobinas, el mercado se divide en bobinas desmontables y bobinas empujables. El segmento de bobinas empujables tuvo la mayor participación del mercado en 2020. Según las cuentas/partículas, el mercado se divide en esféricos y no esféricos. El segmento no esférico empujable tuvo la mayor participación del mercado en 2020. Según la aplicación, el mercado se segmenta en neurología, oncología, cardiología, enfermedades vasculares periféricas y otras. En 2020, es probable que el segmento de oncología tenga la mayor cuota de mercado. El mercado de agentes de embolización por usuario final se segmenta en hospitales, centros quirúrgicos ambulatorios, centros cardíacos y otros. El segmento de hospitales tuvo la mayor participación del mercado en 2020.
Principales fuentes y empresas cotizadas
Algunas de las principales fuentes primarias y secundarias a las que se hizo referencia para preparar este informe sobre el mercado de agentes de embolización en Oriente Medio y Asia. África son sitios web de empresas, informes anuales, informes financieros, documentos de gobiernos nacionales y bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Abbott; Corporación Científica de Boston; cocinar médico LLC; DePuy Synthes; CORPORACIÓN KANEKA; Medtronic; Mérito Medical Systems Inc; Corporación Stryker; y Terumo Corporation, entre otros.
Informe de razones para comprar
- Comprender Oriente Medio y Oriente Medio. Panorama del mercado de agentes de embolización en África e identifique los segmentos del mercado que tienen más probabilidades de garantizar un fuerte rendimiento
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para Medio Oriente y Asia. Mercado de agentes de embolización en África
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en Oriente Medio y Oriente Medio. Mercado de agentes de embolización en África al identificar los segmentos de mercado con las ventas probables más prometedoras
- Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos de Medio Oriente y Asia. Mercado de agentes de embolización en África
- Obtener un pronóstico de ingresos de mercado para el mercado por varios segmentos desde 2021-2028 en Medio Oriente y Asia. Región de África.
ORIENTE MEDIO & SEGMENTACIÓN DEL MERCADO DE AGENTES DE EMBOLIZACIÓN EN ÁFRICA
Por producto
- Bobinas
- Bobinas desmontables
- Bobinas empujables
- Perlas/Partículas
- Esféricas
- No esféricas
- Tapones
- Globos Desmontables
- Pegamento
- Esponja
- Embólicos líquidos
- Esclerosantes
- Agentes precipitantes
- Otros
Por Aplicación
- Oncología
- Neurología
- Urología
- Cardiología
- Enfermedades vasculares periféricas
- Otras
Por usuario final
- Hospitales
- Centros cardíacos
- Centros de cirugía ambulatoria
- Otros
Por país
- Arabia Saudita
- Sudáfrica
- EAU
- Resto de Medio Oriente y Asia África
Perfiles de empresas
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Embolization Agents Market – By Product
1.3.2 MEA Embolization Agents Market – By Application
1.3.3 MEA Embolization Agents Market – By End User
1.3.4 MEA Embolization Agents Market – By Country
2. MEA Embolization Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Embolization Agents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Experts Opinion
5. MEA Embolization Agents Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Surge in the Incidence of Tumors and Aneurysms
5.1.1 Rising Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 High Cost of Embolization Agents
5.3 Market Opportunities
5.3.1 Growing Geriatric Population Base
5.4 Future Trends
5.4.1 Technological Advancements in Embolization Products and Procedures
5.5 Impact analysis
6. Embolization Agents Market – MEA Analysis
6.1 MEA Embolization Agents Market Revenue Forecast and Analysis
7. MEA Embolization Agents Market Analysis – By Product
7.1 Overview
7.2 MEA Embolization Agents Market Revenue Share, by Product (2021 and 2028)
7.3 Coils
7.3.1 Overview
7.3.2 Coils: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Detachable Coils
7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Pushable Coils
7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Beads/Particles
7.4.1 Overview
7.4.2 Beads/Particles: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Spherical
7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2 Non-Spherical
7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Plugs
7.5.1 Overview
7.5.2 Plugs: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Detachable Balloons
7.6.1 Overview
7.6.2 Detachable Balloons: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Glue
7.7.1 Overview
7.7.2 Glue: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Sponge
7.8.1 Overview
7.8.2 Sponge: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Liquid Embolics
7.9.1 Overview
7.9.2 Liquid Embolics: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Sclerosants
7.10.1 Overview
7.10.2 Sclerosants: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11 Precipitating Agents
7.11.1 Overview
7.11.2 Precipitating Agents: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8. MEA Embolization Agents Market Analysis – By Application
8.1 Overview
8.2 MEA Embolization Agents Market, by Application 2021 & 2028 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urology
8.5.1 Overview
8.5.2 Urology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Peripheral Vascular Diseases
8.7.1 Overview
8.7.2 Peripheral Vascular Diseases: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9. MEA Embolization Agents Market Analysis – By End User
9.1 Overview
9.2 MEA Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Centers
9.4.1 Overview
9.4.2 Cardiac Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10. MEA Embolization Agents Market – Country Analysis
10.1 Middle East & Africa: Embolization Agents Market
10.1.1 Overview
10.1.2 Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.2.1 Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Saudi Arabia Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.1.2.2 Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.1.3 Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 UAE Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 UAE: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.2.2.2 UAE: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.1.2.2.3 UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 South Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 South Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.3.2.2 South Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.1.2.3.3 South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.2 Rest of Middle East and Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2.1 Rest of Middle East and Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.4.2.2 Rest of Middle East and Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.1.2.4.3 Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on MEA Embolization Agents Market
11.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12. MEA Embolization Agents Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Medtronic
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Terumo Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Stryker Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Merit Medical Systems Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 DePuy Synthes
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 KANEKA CORPORATION
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)
Table 2. Saudi Arabia Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 11. UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 16. South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East and Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East and Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East and Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms, MEA Embolization Agents Market
LIST OF FIGURES
Figure 1. MEA Embolization Agents Market Segmentation
Figure 2. MEA Embolization Agents Market Segmentation, By Country
Figure 3. MEA Embolization Agents Market Overview
Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in MEA Embolization Agents Market
Figure 5. UAE to Show Significant Growth During Forecast Period
Figure 6. Middle East & Africa PEST Analysis
Figure 7. MEA Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 8. MEA Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. MEA Embolization Agents Market Revenue Share, by Product (2021 and 2028)
Figure 10. Coils: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Beads/Particles: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Plugs: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Detachable Balloons: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Glue: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Sponge: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolics: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sclerosants: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Precipitating Agents: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. MEA Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 21. Oncology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Neurology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Urology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cardiology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Peripheral Vascular Diseases: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 28. Hospitals: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cardiac Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Ambulatory Surgical Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Middle East and Africa: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 34. Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35. UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 38. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa Embolization Agents Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution